abstract |
The subject invention relates to methods and compositions of steroid suspensions suitable for intraocular use in the treatment or prevention of various eye diseases. In particular, this invention provides pharmaceutical compositions having significantly reduced endotoxin levels suitable for intraocular use. The invention also relates to a method of reducing endotoxin levels in certain compositions, such as pharmaceutical compositions, that can be used for intraocular delivery. |